Kinetics of expansion of SIV Gag-specific CD8+ T lymphocytes following challenge of vaccinated macaques.
about
Hypercytotoxicity and rapid loss of NKp44+ innate lymphoid cells during acute SIV infectionReverse genetics technology for Rift Valley fever virus: current and future applications for the development of therapeutics and vaccines.Increased immunogenicity of HIV-1 p24 and gp120 following immunization with gp120/p24 fusion protein vaccine expressing alpha-gal epitopesEstimation of the initial viral growth rate and basic reproductive number during acute HIV-1 infectionCD16- natural killer cells: enrichment in mucosal and secondary lymphoid tissues and altered function during chronic SIV infectionHigh-potency human immunodeficiency virus vaccination leads to delayed and reduced CD8+ T-cell expansion but improved virus controlIs an HIV vaccine possible?CD8+ lymphocytes do not mediate protection against acute superinfection 20 days after vaccination with a live attenuated simian immunodeficiency virusMacaques vaccinated with simian immunodeficiency virus SIVmac239Delta nef delay acquisition and control replication after repeated low-dose heterologous SIV challenge.SIV-specific CD8+ T cells are enriched in female genital mucosa of rhesus macaques and express receptors for inflammatory chemokinesGut inflammation and indoleamine deoxygenase inhibit IL-17 production and promote cytotoxic potential in NKp44+ mucosal NK cells during SIV infection.Vaccine protection against simian immunodeficiency virus in monkeys using recombinant gamma-2 herpesvirus.Understanding the failure of CD8+ T-cell vaccination against simian/human immunodeficiency virus.Estimating the infectivity of CCR5-tropic simian immunodeficiency virus SIV(mac251) in the gut.Understanding the mechanisms and limitations of immune control of HIV.Macaques vaccinated with live-attenuated SIV control replication of heterologous virus.With minimal systemic T-cell expansion, CD8+ T Cells mediate protection of rhesus macaques immunized with attenuated simian-human immunodeficiency virus SHIV89.6 from vaginal challenge with simian immunodeficiency virus.Nonhuman primate models and the failure of the Merck HIV-1 vaccine in humans.Influence of mismatch of Env sequences on vaccine protection by live attenuated simian immunodeficiency virus.The effect of early versus delayed challenge after vaccination in controlling SHIV 89.6P infectionVaccine-induced cellular responses control simian immunodeficiency virus replication after heterologous challengeT-cell vaccine strategies for human immunodeficiency virus, the virus with a thousand faces.Safety, tolerability, and immunogenicity of repeated doses of dermavir, a candidate therapeutic HIV vaccine, in HIV-infected patients receiving combination antiretroviral therapy: results of the ACTG 5176 trial.Diverse recognition of conserved orthopoxvirus CD8+ T cell epitopes in vaccinated rhesus macaques.Carbohydrate targets in HIV vaccine research: lessons from failures.Dynamic Modulation of Expression of Lentiviral Restriction Factors in Primary CD4+ T Cells following Simian Immunodeficiency Virus Infection.Increased immunogenicity of human immunodeficiency virus gp120 engineered to express Galalpha1-3Galbeta1-4GlcNAc-R epitopes.Vaccination with SIVmac239Deltanef activates CD4+ T cells in the absence of CD4 T-cell loss.
P2860
Q27322468-CC52A109-3255-42FA-9639-C7BD69465C68Q33570326-2F3BE4D4-9547-4192-AFC3-22AB28409684Q33837215-F35C180C-6141-40B3-A3FF-4BA49A8474B8Q33877481-F6AC7EC1-95A6-40F0-879B-88A9B8E18F0CQ33896743-0D52CB2C-38B0-44CC-8E6B-2D4E6D84323AQ33908824-F1A5DF5C-C33E-461B-8AD7-59D801DF65D7Q33946263-5F516045-D110-42CD-8982-DA011E476A52Q33984208-A27B928E-B7F6-4357-89EB-3B016AD53072Q34120102-0A20E381-13F6-419C-BBA7-0D946CDA99BEQ34788897-AF2E66BC-89FA-4731-AB87-441804BEAEEFQ35230224-35DC7787-4F3E-42DC-96FF-38E915608DB0Q35531553-A482C961-87B6-4655-ADE6-300DE9E9374BQ35784787-0C51A009-671E-48A9-995F-5A9BB9871E5FQ35947552-F21DAAD2-ADC4-4C64-9061-D69BBBD07076Q36762540-D24C8605-B0C3-4E50-B71F-4B69DDAB65D6Q36946545-05D0143B-A765-448C-B2CB-16DF5F309592Q36949843-0D5869C0-D6E5-41E8-88DC-7BAD15322E21Q36971813-C4D916E8-A303-4258-BA32-E390DD38D2ADQ36978847-32F6156E-FA9F-4A8C-B360-F426B8BFC175Q37148935-597D8E8D-3D34-4C55-8184-7F216D4E2182Q37232824-40BEA6F8-4B66-402B-BB4A-E58510AB61BEQ37333743-A6BA6095-C62C-4C8B-8E59-1C890F5129CAQ37381097-CEA24013-5ACF-4099-AF76-A6F4936A9188Q37395140-73C17BBD-FD32-41FD-BE73-3CF3D6F564E0Q37773298-9AAA3C73-31B1-4796-ACB4-4DC7FEACC3A9Q40366488-6FE970E2-B880-48D9-9E61-A8A4907D1225Q41495119-5612CBCE-BE22-47DD-836A-8DE18BF5D9D0Q41816425-7BB33B48-96A5-4510-ACC7-73626C414550
P2860
Kinetics of expansion of SIV Gag-specific CD8+ T lymphocytes following challenge of vaccinated macaques.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Kinetics of expansion of SIV G ...... llenge of vaccinated macaques.
@en
Kinetics of expansion of SIV G ...... llenge of vaccinated macaques.
@nl
type
label
Kinetics of expansion of SIV G ...... llenge of vaccinated macaques.
@en
Kinetics of expansion of SIV G ...... llenge of vaccinated macaques.
@nl
prefLabel
Kinetics of expansion of SIV G ...... llenge of vaccinated macaques.
@en
Kinetics of expansion of SIV G ...... llenge of vaccinated macaques.
@nl
P2093
P1433
P1476
Kinetics of expansion of SIV G ...... llenge of vaccinated macaques.
@en
P2093
Jacqueline Gillis
John D Altman
Kelledy Manson
Kelly Stefano-Cole
Michael Wyand
R Paul Johnson
Ronald C Montelaro
Ussama M Abdel-Motal
P304
P356
10.1016/J.VIROL.2004.12.030
P407
P577
2005-03-01T00:00:00Z